| Date | Ref. No. | Patent No. | Title |
| 11/4/2009 | E-158-2003/1 | | New Derivative of Dextromethorphan for Use in Neuronal Therapy |
| 7/29/2009 | E-040-2004/0 | 7,504,243 | High-yield Methods of Producing Biliverdin |
| 7/9/2009 | E-128-2006/0 | | Novel Dopamine Receptor Ligands as Therapeutics for Central Nervous System Disorders |
| 7/2/2009 | E-127-1995/0
E-127-1995/1
E-127-1995/2
E-138-1994/0
E-196-2004/0 | 6,884,871
6,924,367
7,049,291
7,148,036
7,220,558
7,563,596 | Novel Osteobiologic Proteins for Treatment of Osteoporosis, Rheumatoid and Neurologic Diseases |
| 7/2/2009 | E-127-1995/0
E-127-1995/1
E-127-1995/2 | 6,884,871
6,924,367
7,049,291
7,563,596 | Isolation And Use Of Tissue Growth-Inducing FRZB Protein |
| 11/1/2008 | E-187-2007/0 | | Indoline Compounds for the Treatment of Spinal Muscular Atrophy (SMA) and Other Diseases |
| 9/1/2008 | E-216-2007/0 | | Use of Razoxane for the Treatment of Alzheimer's Disease |
| 9/1/2008 | E-153-2005/2 | | Prevention and Treatment of Multiple Sclerosis (MS) by Administering E-Selectin |
| 8/1/2008 | E-182-2007/0 | | Methods for Promoting Stem Cell Proliferation and Survival |
| 8/1/2008 | E-101-2004/0 | | Treatment of Alcoholism by Inhibition of the Neuropeptide Y Receptor |
| 7/1/2008 | E-211-2006/0 | | Therapeutic Application of Fatty Acid Amide Hydrolase Inhibitors |
| 6/1/2008 | E-245-2006/0 | | Novel Isoform of KCNH2 for the Treatment of Schizophrenia |
| 5/1/2008 | E-206-1995/3 | 6,320,022
7,101,548 | Treatment and Diagnosis of Cancer, Diabetes and other Disorders Using Adrenomedullin Peptides and Antibodies |
| 2/1/2008 | E-203-2000/0 | 7,144,918 | Biologically Active Macrolides, Compositions and Uses Thereof |
| 1/1/2008 | E-153-2007/0 | | Nitroxide Radical as a Treatment for Neurodegeneration |
| 7/1/2007 | E-059-2006/0 | | Method of Treating or Preventing Oxidative Stress-related Diseases (stroke and neurodegenerative diseases, wound healing and cardiovascular diseases) |
| 5/1/2007 | E-133-2006/1 | | New Compounds and Methods for the Treatment of Spinal Muscular Atrophy and Other Diseases |
| 4/1/2007 | E-239-2005/0 | | Method for Promoting Stem Cell Proliferation and Survival |
| 4/1/2007 | E-103-2000/0
E-103-2000/1
E-103-2000/2
E-305-2005/0 | 6,753,317
6,916,905 | Novel Dmt-Tic Analogues Specific for Delta- and Mu-Opioid Receptors |
| 12/1/2006 | E-295-2005/0 | | Novel Treatments for Autoimmune Neuroinflammatory Diseases including Multiple Sclerosis |
| 9/1/2006 | E-271-2005/0 | | Novel Treatment of Vascular Cognitive Impairment |
| 8/1/2006 | E-336-2001/0 | | Amyloid Beta is a Ligand for FPR Class Receptors |
| 5/1/2006 | E-305-2005/0 | | Potent Pharmacophoric Delta- and Mu-Opioid Receptor Antagonists and Conversion of Endomorphin Mu-Opioid Agonists to Antagonists |
| 5/1/2006 | E-075-2003/0 | | Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof |
| 3/1/2006 | E-262-1999/1 | 7,459,536 | Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer |
| 2/1/2006 | E-175-2004/0 | | Rapid Anti-Depressant Response Produced by Low Dose Treatment with Anti-Muscarinic Drugs |
| 1/1/2005 | E-130-2004/0 | | Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson’s and Alzheimer’s Disease |
| 12/1/2004 | E-071-2000/0 | 6,468,524 | AAV4 Vector and Uses Thereof |
| 12/1/2004 | E-072-2000/0 | 6,855,314 | AAV5 Vector for Transducing Brain Cells and Lung Cells |
| 6/1/2004 | E-035-2004/0
E-035-2004/1
E-035-2004/2
E-035-2004/3 | | Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration to Sites of Brain and Spinal Cord Injury |
| 2/1/2004 | E-091-2003/0 | | Methods for the Treatment of Parkinson's Disease and Other alpha-synucleinopathies |
| 12/1/2003 | E-109-2000/0 | | Pain Control by the Selective Local Ablation of Nociceptive Neurons |
| 7/1/2003 | E-251-2002/0
E-251-2002/1 | | Structurally Rigid Dopamine D3 Receptor Selective Ligands as Cocaine and Methamphetamine Abuse Therapeutics |
| 8/1/2002 | E-247-2001/0 | | Methods of Diagnosing and Treating Schizophrenia |
| 5/1/2002 | E-206-2000/0
E-206-2000/1 | | Enhanced Distribution of Therapeutic Agents After Local Delivery |
| 4/1/2002 | E-174-2000/0 | | Effect of COMT Genotype on Frontal Lobe Function |
| 12/1/2001 | E-209-2001/0
E-209-2001/1
E-209-2001/2 | 7,427,590 | Neurotrophic Components of the ADNF I Complex |
| 12/1/2001 | E-209-2001/0 | | Neurotrophic Components of the ADNF I Complex |
| 9/1/2001 | E-141-2000/0 | 7,153,882 | Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof |
| 5/1/2001 | E-203-1994/0 | 5,693,779 | Production and Use of Anti-Dorsalizing Morphogenetic Protein |
| 5/1/2001 | E-222-2000/0 | | Novel Inhibitors of p53 for Treatment of Neurodegenerative Disorders, Myocardial Infarction and Other Tissue Insults |
| 12/1/2000 | E-123-1999/0 | 7,122,624 | PTH2 and PTH1 Receptor Ligands |
| 8/1/2000 | E-041-2000/0 | 6,448,245 | HIV Protease Inhibitors, Ritonavir and Saquinavir are Potent Inhibitors of Calcium Activated Neutral Peptidases, Calpains |
| 5/1/2000 | E-301-1999/0 | 6,881,718 | Novel Disulfide Conjugated Cell Toxins and Methods of Making and Using Them |
| 6/1/1999 | E-044-1998/0 | 6,596,269 | Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain |
| 3/1/1999 | E-023-1996/0
E-023-1996/1
E-023-1996/2 | 6,316,423 | Method of Treating Ischemic, Hypoxic, and Anoxic Brain Damage |
| 2/1/1999 | E-235-1998/0 | 6,787,356 | Cell Expansion System For Use In Neural Transplantation |
| 10/1/1998 | E-218-1997/0 | 6,068,844 | The Application Of Induction Tolerance By Oral Feeding Of Myelin Basic Protein To The Generation Of Increased Resistance To Stroke |
| 10/1/1998 | E-287-1997/0
E-287-1997/1
E-287-1997/2 | 6,630,507 | Cannabinoids As Neuroprotectants |
| 5/1/1997 | E-152-1996/0 | 6,387,389 | Sustained-Release Derivatives of Hydroxylated Analogs of Substituted 1-
[2[bis(aryl)methoxy]-ethyl] -Piperazines and -Homopiperazines and Their
Use as Noncompetitive Antagonists of Dopamine Reuptake Inhibitors |
| 1/1/1997 | E-050-1996/0 | 6,156,765 | 2,2'-Bipyridyl, a Ferrous Chelator, Prevents Vasospasm in a Primate Model of Subarachnoid Hemorrhage |
| 1/1/1997 | E-132-1996/0 | 6,780,413 | Immunotoxin (MAB-RICIN) For The Treatment Of Focal Movement Disorders |
| 12/1/1996 | E-078-1995/1 | 5,792,775 | 4'- And 4',4"-Substituted-3alpha(diphenylmethoxy)tropane Analogs As Cocaine Therapeutics |
| 3/1/1996 | E-171-1994/0 | 5,780,589 | Application of Highly Potent and Ultraselective delta Opioidmimetic Peptide Antagonists for Biochemical, Pharmacological, Clinical and Therapeutic Studies |